1. Home
  2. OXLC vs LMAT Comparison

OXLC vs LMAT Comparison

Compare OXLC & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OXLC
  • LMAT
  • Stock Information
  • Founded
  • OXLC 2010
  • LMAT 1983
  • Country
  • OXLC United States
  • LMAT United States
  • Employees
  • OXLC N/A
  • LMAT N/A
  • Industry
  • OXLC Investment Managers
  • LMAT Medical/Dental Instruments
  • Sector
  • OXLC Finance
  • LMAT Health Care
  • Exchange
  • OXLC Nasdaq
  • LMAT Nasdaq
  • Market Cap
  • OXLC 1.7B
  • LMAT 1.8B
  • IPO Year
  • OXLC N/A
  • LMAT 2006
  • Fundamental
  • Price
  • OXLC $3.45
  • LMAT $84.47
  • Analyst Decision
  • OXLC Strong Buy
  • LMAT Buy
  • Analyst Count
  • OXLC 1
  • LMAT 6
  • Target Price
  • OXLC $6.00
  • LMAT $100.80
  • AVG Volume (30 Days)
  • OXLC 1.9M
  • LMAT 104.7K
  • Earning Date
  • OXLC 11-01-2023
  • LMAT 08-05-2025
  • Dividend Yield
  • OXLC 18.86%
  • LMAT 0.96%
  • EPS Growth
  • OXLC N/A
  • LMAT 30.45
  • EPS
  • OXLC 1.20
  • LMAT 1.97
  • Revenue
  • OXLC $130,145,365.00
  • LMAT $226,256,000.00
  • Revenue This Year
  • OXLC $136.15
  • LMAT $13.88
  • Revenue Next Year
  • OXLC $5.51
  • LMAT $8.81
  • P/E Ratio
  • OXLC $4.24
  • LMAT $42.43
  • Revenue Growth
  • OXLC N/A
  • LMAT 13.19
  • 52 Week Low
  • OXLC $4.41
  • LMAT $71.42
  • 52 Week High
  • OXLC $5.70
  • LMAT $109.58
  • Technical
  • Relative Strength Index (RSI)
  • OXLC 27.32
  • LMAT 57.73
  • Support Level
  • OXLC $3.27
  • LMAT $79.01
  • Resistance Level
  • OXLC $4.23
  • LMAT $83.33
  • Average True Range (ATR)
  • OXLC 0.13
  • LMAT 1.96
  • MACD
  • OXLC -0.03
  • LMAT 0.15
  • Stochastic Oscillator
  • OXLC 20.00
  • LMAT 100.00

About OXLC Oxford Lane Capital Corp.

Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

Share on Social Networks: